Order Article Reprints

Kennedy DJ, Khalaf FK, Sheehy B, Weber ME, Agatisa-Boyle B, Conic J, Hauser K, Medert CM, Westfall K, Bucur P, et al. Telocinobufagin, a Novel Cardiotonic Steroid, Promotes Renal Fibrosis via Na⁺/K⁺-ATPase Profibrotic Signaling Pathways. International Journal of Molecular Sciences. 2018; 19(9):2566. https://doi.org/10.3390/ijms19092566

Kennedy, David J., Fatimah K. Khalaf, Brendan Sheehy, Malory E. Weber, Brendan Agatisa-Boyle, Julijana Conic, Kayla Hauser, Charles M. Medert, Kristen Westfall, Philip Bucur, and et al. 2018. "Telocinobufagin, a Novel Cardiotonic Steroid, Promotes Renal Fibrosis via Na⁺/K⁺-ATPase Profibrotic Signaling Pathways" International Journal of Molecular Sciences 19, no. 9: 2566. https://doi.org/10.3390/ijms19092566

Kennedy, D. J., Khalaf, F. K., Sheehy, B., Weber, M. E., Agatisa-Boyle, B., Conic, J., Hauser, K., Medert, C. M., Westfall, K., Bucur, P., Fedorova, O. V., Bagrov, A. Y., & Tang, W. H. W. (2018). Telocinobufagin, a Novel Cardiotonic Steroid, Promotes Renal Fibrosis via Na⁺/K⁺-ATPase Profibrotic Signaling Pathways. International Journal of Molecular Sciences, 19(9), 2566. https://doi.org/10.3390/ijms19092566